Wu et al. reported that the staining of CD44 was significantly linked with a lower response rate chemoradiation therapy, and concluded that CD44-positive bladder cancer cells appeared more resistant to irradiation [32]. The gene discussed is CD44; the disease is urinary bladder cancer.